Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
Ventyx Biosciences
Biotech
Atai, Eli Lilly, Novartis & more—Chutes & Ladders
Atai announces CEO transition plans. Lilly's Alonzo Weems will retire after 27 years. Novartis China President set to lead all ex-US commercial work.
Max Bayer
,
Gabrielle Masson
May 17, 2024 8:30am
Former FDA leader Woodcock inspires Biotech Sisterhood summit
Apr 24, 2024 9:23am
Ventyx lays off 20% of staff after cutting TYK2 indications
Dec 8, 2023 8:45am
Ventyx stock drops 70% as TYK2 inhibitor psoriasis plans halted
Nov 7, 2023 7:23am
Ventyx misses with investors amid comparisons to BMS, Pfizer
Oct 10, 2023 6:30am
Ventyx nabs an upsized IPO to challenge BMS' Zeposia
Oct 21, 2021 9:20am